首页> 外文期刊>Journal of experimental & clinical cancer research : >Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans
【24h】

Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans

机译:兽医患者的辅助化疗:规划人类未来疗法的模型

获取原文
           

摘要

The treatment of soft tissue tumors needs the coordinated adoption of surgery with radiation therapy and eventually, chemotherapy. The radiation therapy (delivered with a linear accelerator) can be preoperative, intraoperative, or postoperative. In selected patients adjuvant brachytherapy can be adopted. The goal of these associations is to achieve tumor control while maximally preserving the normal tissues from side effects. Unfortunately, the occurrence of local and distant complications is still elevated. Electrochemotherapy is a novel technique that combines the administration of anticancer agents to the application of permeabilizing pulses in order to increase the uptake of antitumor molecules. While its use in humans is still confined to the treatment of cutaneous neoplasms or the palliation of skin tumor metastases, in veterinary oncology this approach is rapidly becoming a primary treatment. This review summarizes the recent progresses in preclinical oncology and their possible transfer to humans.
机译:软组织肿瘤的治疗需要通过放射疗法和化学疗法来协调采用外科手术。放射治疗(使用线性加速器提供)可以在术前,术中或术后进行。在选定的患者中,可以采用辅助近距离治疗。这些关联的目标是在最大程度地保护正常组织免受副作用的同时实现肿瘤控制。不幸的是,局部和远距离并发症的发生率仍然很高。电化学疗法是一种新颖的技术,将抗癌药的给药与通透性脉冲的应用相结合,以增加抗肿瘤分子的摄取。尽管其在人类中的用途仍仅限于皮肤肿瘤的治疗或皮肤肿瘤转移的缓解,但在兽医肿瘤学中,该方法正迅速成为主要治疗方法。这篇综述总结了临床前肿瘤学的最新进展及其可能转移给人类。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号